Numerous NAAA inhibitors have been designed and regarded as efficient pharmacological tools in the control of various pathological conditions by reducing nicotine dependence [36], alleviating osteoarthritis development [37], and attenuating inflammatory and neuropathic pain [6]. This evidence concerns the gene NAAA and substance dependence.